fda warning letters glp-1 compounders september 2025 warns against compounded medications The FDA should require negative

According to Xuewei et al., 2003, the upregulation of integrins CD11b/CD18 and CD14 due to hyperhomocysteinemia is important in the release of hydrogen peroxide, oxidase activity, transendothelial migration and monocyte adherence to endothelial cells [60]

M.La VigneraS.VicariE.CalogeroA

Previous serious hypersensitivity reactions, current pregnancy (especially for weight-loss indications), active pancreatitis and severe gastroparesis generally contraindicate use

Contraindications: Not for use in individuals with a history of cancer, those who are pregnant or breastfeeding, or anyone under 18

The published preclinical work (Neelakantan et al., referenced via PMC5826726) reported clean safety at 20 mg/kg subcutaneous in mice over 11 days